Journal Reports: Investing Monthly
AARP-Branded Medicare Drug Plan Is Too Costly for Many Retirees, Critics Say
By R, andall Smith
November 4, 2022 at 2:00 PM ET
The popular plan’s price has risen sharply in recent years—prompting some experts to suggest enrollees consider switching.
Amazon Earnings Are Today. All Eyes Are on Its Cloud Computing Business.
For years, Wall Street groused about Silicon Valley’s refusal to pay dividends and buy back stock as tech companies grew...
(Bloomberg) -- The stock rout in Gautam Adani’s beleaguered empire intensified to more than $100 billion, as the fallout from...
Dow Jones futures fell slightly overnight, while S&P 500 futures and especially Nasdaq futures rose with Facebook parent Meta Platforms...
